the International Classification of Diseases, Clinical Modification, are specific to this stage. The NPUAP recommends that DTI be coded as "pressure ulcer, unstageable"; however, the Agency for Healthcare Research and Quality considers hospital-acquired unstageable pressure ulcers a Patient Safety Indicator-a reflection of quality of care. In turn, the Centers for Medicare & Medicaid Services' Value-Based Purchasing program uses Patient Safety Indicator data to determine whether to pay or withhold payment for services. Thus, DTI documentation not only conveys uncertain clinical ramifications but also may result in adverse quality and fiscal metrics for hospital systems.
Overall, these findings highlight that pressure ulcers should not be used as hospital-based quality measures until evidence-based interventions that yield improved outcomes are available, particularly when public reporting and financial sanctions may be tied to them. We recommend that DTIs be rigorously studied before they are considered a distinct clinical entity and that they not be associated with any quality or reimbursement metrics. 
IN RESPONSE:
As Dr. Padula and colleagues rightfully point out, the evidence linking specific pressure ulcer risk assessment tools with such outcomes as a decrease in pressure ulcers is inconclusive. We also found insufficient evidence to determine the superiority of any 1 tool over the others or over clinical gestalt for predicting pressure ulcers. The American College of Physicians' guideline does not recommend against using pressure ulcer risk assessment tools or intend to discourage this practice. However, in the absence of evidence, we cannot promote the use of these tools over clinical judgment and leave the decision of risk assessment up to the care provider.
Dr. Kowalski and associates raise the important point that developing performance measures for many chronic conditions, such as pressure ulcers, is challenging. We agree that these measures should be based on robust scientific evidence in the areas that show clinical benefit rather than on statistical data or expert opinion. 
Mary Ann Forciea, MD

Treatment of Pressure Ulcers
TO THE EDITOR: I read Qaseem and colleagues' guideline with interest (1) . Pressure ulcers are a tough problem to manage and a horrible one for patients, negatively affecting mortality, morbidity, quality of life, and health care costs. Different treatment strategies could and should be integrated to achieve healing (2) . However, Qaseem and colleagues' guideline highlights that most interventions are supported by lowquality evidence and that recommendations on their use are based on expert consensus (1) . This synthesis of literature is consistent with that of the international guideline released in September 2014 by the National Pressure Ulcer Advisory Panel (NPUAP), European Pressure Ulcer Advisory Panel (EPUAP), and Pan Pacific Pressure Injury Alliance (PPPIA) (3) .
In respect to nutritional care, Qaseem and colleagues recommend protein or amino acid supplementation to reduce wound size. However, as often happens, guidelines cover a defined review time and evidence from most recent trials is lost. Specifically, a high-quality trial (OEST [OligoElement Sore Trial]) (4) has shown that malnourished patients with pressure ulcers receiving high-calorie, high-protein nutritional support (approximately 30 to 35 kcal/kg/d and protein, 1.5 g/kg/d) achieve improved healing when a mix of micronutrients (arginine, zinc, and antioxidants) involved in tissue regeneration is also provided. Despite covering a similar review time as Qaseem and colleagues' guideline, the NPUAP/ EPUAP/PPPIA guideline (3) also includes a moderate-strength recommendation on the use of arginine and micronutrientenriched nutritional support. Because of the results of OEST (4), this intervention is now expected to become a highstrength recommendation.
Although Qaseem and colleagues' guideline does not specifically indicate the amount of calories and protein to be supplied, it clearly emphasizes the importance of nutritional care and of delivering more tailored nutritional support that should include but not be limited to high amounts of calories and proteins as suggested in OEST (4) and a previous metaanalysis (5) . This approach applies at least to patients who are malnourished or at nutritional risk, an aspect pointed out many times in the NPUAP/EPUAP/PPPIA guideline (3). These patients are more likely to be compromised, depleted, and unable to meet energy needs (5) . On the other hand, most patients with pressure ulcers are at nutritional risk (4) . Therefore, it is reasonable to state that pressure ulcer care without attention to nutrition is incomplete. Nutritional screening and support should systematically be considered in the management of every patient with pressure ulcers. (1) is that "clinicians use protein or amino acid supplementation in patients with pressure ulcers to reduce wound size." They note that "evidence for the optimal dose or form of protein was insufficient."
Of the 14 cited studies, 5 focus on arginine supplementation and 1 each on a proprietary formulation; a collagen protein hydrolysate; and ornithine ␣-ketoglutarate, presumably the recommended amino acid supplementation. Of the 5 studies of arginine, that of Benati and associates (n = 16; 3 groups; duration, 2 weeks) (2) provides no statistics. Brewer and coworkers' study (n = 35) (3) uses historical control participants. Desneves and colleagues' study (n = 16; 3 groups; duration, 3 weeks) (4) finds worse outcomes with protein supplementation unless it is enriched with arginine. Meaume and associates' study (n = 23; duration, 3 weeks) (5) compares 2 doses of arginine and concludes that they are equally effective. van Anholt and coworkers' study and the title of the journal in which it was published were not found in PubMed or Google Scholar. Qaseem and colleagues also note that the relationship between reduction in wound size and complete healing is uncertain.
This recommendation supporting a protean and undefined intervention to achieve an outcome of uncertain importance based on evidence categorized as "low quality" in 1 place and "moderate quality" in another promotes and lends credence to a multibillion-dollar industry that is based largely on credulity. 
TO THE EDITOR:
We appreciate that Qaseem and colleagues (1) have written a clinical practice guideline for the treatment of pressure ulcers based on the best available evidence. However, we would like to comment on their literature search methods and omission of the use of donut cushions and provide caveats about their recommendations for nutrition supplementations.
Many research advances about pressure ulcer treatment have recently taken place. Searching the literature from the inception of databases may overshadow the more important and recent studies. We agree that all literature should be reviewed, but recent studies should take precedence over those published decades ago.
Qaseem and colleagues found no difference (albeit according to low-quality evidence) with vitamin C supplementation but recommended protein supplementation. We agree with Dr. Cereda that protein or micronutrient supplementation alone may be necessary but insufficient to heal pressure ulcers. Most articles in a systematic review by Choo and asso-ciates (2) also found that protein supplements alone did not promote pressure ulcer healing. However, protein supplements enriched with arginine, zinc, vitamin C, or other antioxidants showed statistically significant wound healing. On the basis of these data, we urge Qaseem and colleagues to update and clarify their pressure ulcer guidelines.
Finally, we are disappointed that they omitted mentioning donut cushions. The NPUAP has repeatedly recommended against them because they increase tissue pressure at the wound edge, thereby decreasing circulation and worsening edema (3). However, many physicians and patients are unaware of this harm. A survey found that more than half of critical care physicians believe that donut cushions are recommended (4). Anecdotally, we continue to see providers with various levels of experience from medical and surgical specialties make this mistake, probably because of a lack of education during residency (4). Also, patients can readily purchase donut cushions. Just search on any Internet engine to see the number of vendors and customer reviews! Are we as providers routinely and specifically asking patients what they are using? It is essential to explicitly address the harm of donut cushions.
We are pleased that the American College of Physicians is trying to improve physician awareness and agree that further research on pressure ulcers is needed to inform practice.
We urge readers to review the comprehensive 2014 Prevention and Treatment of Pressure Ulcers: Clinical Practice Guideline that was collaboratively published by the NPUAP, EPUAP, and PPPIA (5).
Jill Monfre, PhD, RN, CWOCN Justin Endo, MD
University of Wisconsin Madison, Wisconsin
TO THE EDITOR:
The International Pressure Ulcer Guideline Development Group (GDG), which comprised representatives from the NPUAP, EPUAP, and PPPIA, congratulates Qaseem and colleagues on the recent publication of their pressure ulcer prevention (1) and treatment (2) guidelines. These guidelines make an important contribution to the field by presenting available evidence on the comparative effectiveness of risk assessment, prevention, and treatment of pressure ulcers.
The GDG released a comprehensive, evidence-based guideline on pressure ulcer prevention and treatment in 2014 (3), updating the 2009 NPUAP/EPUAP guideline (4). Qaseem and colleagues and the GDG used rigorous methods to examine direct evidence on pressure ulcer prevention and treatment. Qaseem and colleagues' recommendations are consistent with those of the GDG.
The GDG identified limitations in direct evidence but was driven to provide evidence-based guidance because clinicians face real decisions about pressure ulcer prevention and treatment. Rather than remain silent on important aspects of pressure ulcer care not addressed by research, the GDG developed a method for evaluating indirect evidence (for example, using healthy humans in biomechanical studies, bench research from animal and cell culture models, and studies of chronic wounds).
Expert opinion was used when direct or indirect evidence was unavailable. Many "expert opinion" recommendations provided guidance on how to implement evidence-based recommendations. All recommendations were made available for review by members of the sponsoring organizations, guideline working groups, and approximately 1000 stakeholders in 63 countries. All comments were carefully considered before finalizing the guideline. The GDG then formally evaluated the recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method.
Black's editorial accompanying Qaseem and colleagues' guidelines (5) highlights situations in which "research alone" does not provide adequate clinical guidance. However, it may have created the impression that most recommendations in the 2014 international guideline were based solely on expert opinion. In fact, many were based on indirect evidence.
We agree that more quality research is needed. Given the substantial lack of evidence addressing pressure ulcer management today, these gaps are unlikely to be closed in the near future. Concurrently, there is a need to provide best evidence-based practices at the bedside. Guidelines that leave unanswered questions might be of limited help. The GDG believes that consideration of indirect evidence and expert opinion using a transparent and unbiased process is necessary and appropriate in the development of clinically relevant recommendations when direct research evidence is lacking.
Janet E. Cuddigan, PhD, RN, CWCN University of Nebraska Medical Center Omaha, Nebraska
Jan Kottner, PhD Charité -Universitä tsmedizin Berlin, Germany
Emily Haesler, BN, PGradDipAdvNurs
Australian National University Canberra, Australia
On behalf of the International Pressure Ulcer Guideline Development Group
IN RESPONSE:
We agree with Dr. Cereda that nutrition is an important component of pressure ulcer treatment and found moderate-quality evidence that protein-containing nutritional supplements resulted in wound improvement. We are aware of the recent Annals article on arginine supplementation and, although it was not included in our evidence review because it was published after our literature search dates, it would likely be included in an update of the guideline. In response to Dr. Finucane's comments about nutritional data, although the protein supplementation studies used various formulations, these supplements overall showed benefits for pressure ulcer outcomes and are therefore a suitable treatment option in conjunction with other therapies.
To address Drs. Monfre and Endo's concerns, we reiterate that the guideline is based on a systematic evidence review done by an experienced evidence-based practice center commissioned by the Agency for Healthcare Research and Quality. The reviewers used well-established methods for acquiring, summarizing, and grading the evidence and included experts in the field during the review's development, as well as during public comment and peer review periods. This guideline follows the recently published standards from the Guidelines International Network and Institute of Medicine (1, 2). As for donut cushions, no studies on these cushions met the inclusion criteria in the evidence review; thus, we did not discuss this intervention. Furthermore, identifying every available device that has or has not been studied for harm or benefit was beyond the scope of the guideline.
Dr. Cuddigan and colleagues seek advice beyond what is available from direct evidence. However, a guideline, by definition, should be based on a systematic literature review and not expert opinion (1, 2) , and the American College of Physicians' guidelines are always based on evidence from such reviews. Although we agree that clinicians need guidance even in the absence of direct evidence, such resources as point-ofcare tools, as opposed to guidelines, are better suited to provide this advice.
Differences Between Early and Late Readmissions Among Patients
TO THE EDITOR: Graham and colleagues (1) found that early readmissions were associated with markers of acute illness burden and late readmissions were associated with markers of chronic disease burden; they conclude that the time frame of 30 days after hospital discharge may not be homogeneous. As the authors note, the 30-day time frame used by the Centers for Medicare & Medicaid Services for their readmission reduction program probably penalizes hospitals for factors beyond their control and a narrower window is warranted.
Graham and colleagues performed a sensitivity analysis at a 5-day cut point; when they found no significant difference, they chose a 7-day cut point and found significant results, thereby using readmission within 7 days as their definition of "early readmission." They did not provide a rationale
IN RESPONSE:
We apologize if our text was unclear. When we stated that the cut point of 5 days used in our sensitivity analysis was "not substantially different," we meant relative to the 7-day results, not that the results were no longer significant. In fact, we performed this sensitivity analysis specifically to determine whether our findings were robust enough to justify the specific cut point used. The results show that whether 5 or 7 (or, we suspect, 6 or 8) days is used as the cutoff, the message is still the same: Early readmissions differ from late readmissions.
There is no "actual science" on which to base our choice of which day to use for a cutoff, because this issue has not been studied. We based our decision on clinical judgment, expert opinion, and a close look at the distribution of our data by the day after discharge. We did not simply use comfortable numbers as you suggest. In Figure 2 of our article, it seems that the distribution changes somewhat regarding the number of readmissions on any given day approximately 7 to 8 days after discharge. We hope that this approach was adequate to design our outcome, for which essentially no data were available on which to base our decision.
Lastly, although it is reasonable to extrapolate from our study that a narrower window may be necessary, the main conclusions stated in our article are that the time frame is not homogeneous and that early and late readmissions may require different prevention strategies. Further study is needed to determine the larger health policy implications of these findings.
Kelly L. Graham (2) . However, this test is still widely used for screening in the United States, and understanding why this practice persists is important.
Objective: To measure the percentage of PSA tests in U.S. adult men that are done on a physician's recommendation versus a patient's request.
Methods and Findings:
The National Health Interview Survey collects information through an annual survey of people in their homes, using a complex, stratified, multistage sample design to provide nationally representative data. The survey oversamples black, Hispanic, and Asian persons to increase the precision of the estimates for these populations. Each participant provides verbal consent for survey participation. We used data from the 2013 survey to measure the experiences of 7814 men (aged 40 to 70 years) without prostate cancer during the 12 months before the survey.
The Table shows our principal results. Thirty-five percent of men received a recommendation from their physicians, and approximately 22% of men had PSA screening. More than half of those who received a recommendation were actually screened, but only approximately 3% of cases were screened due to patient initiation. However, more than 90% of those 
